CAMBRIDGE, Mass., May 12 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) will webcast its corporate
presentation at the Bank of America Health Care Conference. The
presentation and discussion will be delivered by Ian Smith, Vertex's
Executive Vice President and Chief Financial Officer, and John Alam, M.D.,
Vertex's Executive Vice President, Medicines Development and Chief Medical
Officer, on Wednesday, May 17, 2006 at 10:40 a.m. PDT (1:40 p.m. EDT).
The presentation and discussion will be webcast live and may be
accessed by visiting the Vertex website at http://www.vrtx.com. A replay of
the webcast will also be available on the Company's website until June 1,
2006. To access the webcast, go to Vertex's website and select 'Bank of
America Health Care Conference 2006.' To ensure a timely connection to the
webcast, it is recommended that users register at least 15 minutes prior to
the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes
the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com/
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations of
Vertex, +1-617-444-6755
|
